Digital frailty tests reduce full checks by 62.3%

Digital frailty tests can reduce the need for full checks by 62.3% in clinical trials.

Digital frailty tests are being used to screen out patients who are unlikely to benefit from clinical trials, reducing the need for full checks by 62.3%. This approach uses machine learning algorithms to analyze patient data and identify those who are unlikely to respond to treatment. By excluding these patients, clinical trials can be more efficient and effective.